  AstraZenecaThe company is recognised as having one of the best development pipelines in the industry and spends over $10 million (£7 million, SEK104 million) each working day to maintain a flow of new medicines designed to meet patients' needs. Worldwide sales in 2001 totalled $16.5 billion (£11.4 billion, SEK173.7 billion) with an operating profit of $4.2 billion (£2.9 billion, SEK43.8 billion). AstraZeneca is committed to building on this success, using its leading position in many important areas of medicine to make a difference to the lives of patients and the healthcare professionals who treat them. Headquartered in the UK, with R&D headquarters in Sweden and a strong presence in the important US market, AstraZeneca sells in over 100 countries, manufactures in 20 countries and has major research centres in 5. It employs over 54,000 people worldwide and values the diversity of skills and abilities that they bring to the business.  Useful information Quiz game Contents About... E-mail |